Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04801654

GMK Sphere TiNb Total Knee Arthroplasty PMS Study

Total knee arthroplasty (TKA) is one of the success stories of modern surgery, providing high patient satisfaction outcomes. Total knee prostheses are generally composed by a femoral component articulating on a polyethylene insert and a tibial tray.

Recently there has been particular attention on the component material; traditionally femoral components are made of cobalt alloys while tibial baseplates are made, in the great majority of cases, of metallic materials, but also polyethylene versions are available. There has been a degree of acceptance in some countries that metal related pathology may exist as demonstrated by the Australian Arthroplasty register where metal hypersensitivity was reported as the fifth most common cause for revision hip arthroplasty 2012 report, making up for 5.9% of all revisions. The wording was subsequently changed from "metal sensitivity" to "metal related pathology" in the 2014 report with 0.5% of all revision total hip arthroplasties (THA) associated with this term. The same change in terminology was used for TKA with metal sensitivity as a cause for revision in 1.3% of revisions in 2012 and in 2014, 1.8% of revision TKAs attributed to "metal related pathology" . The overall revision rate was 3.45% after 10 years in 396.472 TKAs, suggesting a revision rate of 0.06-0.32% secondary to metal or cement allergies. Up to today there is no question that metallic implants may generate wear debris that cause local reactions. This local reaction is not dose related nor predictable and therefore not purely due to the toxic effect of the debris but possibly due to an immunological host process. Hypersensitivity to metal undoubtedly exists but it cannot be stated at the moment to be an allergic reaction. To prevent issues arising due to metal related pathology, alternative solutions to conventional chrome cobalt material have been proposed, for example ceramic component or implant coating. In particular, TiNbN coating has been proposed by most companies thanks to its excellent biological properties. Preclinical studies have showed a high scratch resistance and low coefficient of friction, more resistance to fretting corrosion, reduction of wear, lower ion release rates and low fatigue cycle, as described in the review of Hove. Clinically, cohort of studies of TiN-coated implants showed an overall survival exceeding 90% with a follow-up of 15 to 77 months and good clinical outcomes. No reports of adverse effects related to TiN coating of CoCrMo knee implants have been showed. There are few studies that compared TiN-coated implants with the same uncoated version. Thienpont, comparing TiN-coated and uncoated CoCrMo implants, showed similar clinical and radiological outcomes at short-term follow up in both patients groups .

Overall we can conclude that in literature no adverse events have been reported concerning the TiNbN coating and in particular it has been showed that the coating doesn't not affect the performance of the device if compared with the same uncoated version.

The aim of this study is to evaluate the long term clinical and radiological performance of GMK Sphere total knee component, coated version.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

IRCCS Istituto Ortopedico Galeazzi di Milano Sede di via Monreale18 (Istituto Clinico San Siro)

Milan, MI, 20148, Italy

Location status: Recruiting

Location contact

Marco Attanasio, Dr

CONTACT

marco attanasio <[email protected]>

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Those older than 18 years old at the surgery time
  • those suitable to undergo to a primary total knee arthroplasty for whom the GMK Sphere TiNb coated device will be implanted (according to the label indication/contraindications)
  • Patients who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to patient's surgery

Exclusion criteria

  • Those patients with metal implants containing Co, Cr and / or Ni
  • Those patients who have had environmental or occupational exposure to toxic metals such as Co, Cr and / or Ni (solvents, industrial paints, welders)
  • Those whose mental conditions may compromise their ability to provide informed consent to study participation, ability to complete questionnaires or complete 10-year follow-ups
  • Those unable to give their consent to participate in the study or who do not want to participate
  • Any condition not mentioned in inclusion criteria.

Treatment and study plan

Blood sample

Diagnostic Test

preoperative and at 6 months and 1 year follow-up after the surgery the patients will take a blood sample

Primary outcomes

  1. Long term performance

    Time frame: 10 years

    Device survival will be assessed by Kaplan Maier curve

Secondary outcomes

  1. Clinical performance

    Time frame: 6 months, 1, 5 and 10 years after surgery

    Clinical performance will be assessed through the NEW KSS score collected during preoperative and follow-up visits. The score is divided in subscale: objective (0-75), Symptoms (0-25), Satisfaction (0-40), Expectation (0-15), Functional Activities (0-30), high scores indicating good outcomes.

  2. Radiological performance

    Time frame: (1, 5 and 10 years after surgery

    standard x-ray exam performed preoperatively and postoperatively before discharge from hospital and during follow-up visits

  3. Retropatellar pain

    Time frame: 6 months and 1, 5 and 10 years after surgery

    Kujala score collected during preoperative visit and follow-up visit. Each scale ranges from 0 to 100 with high scores indicating good outcomes.

  4. Ion release rate

    Time frame: preoperative, 6 months and 1 year visits

    blood level of ions Co, Cr and Ni in a subgroup of 30 patients

  5. Activity level after surgery

    Time frame: 6 months and 1year after surgery

    UCLA Activity score collected during preoperative visit and follow-up visit. 1-10 scale with 1 less active, to 10 more active.

  6. Rate of complications

    Time frame: up to 10 years after surgery

    collection of all adverse events occurred

Study contacts

Contact information is provided by the study sponsor or research team.

Franco Parente, Dr

CONTACT

[email protected]

+390248785210

Sponsors and collaborators

Lead sponsor

Medacta International SA

Industry

Registry information

Official study title

A Monocentric, Prospective Clinical Survey on Long Term Performance of GMK Sphere Total Knee Arthroplasty

Important dates

Study start
2020
Primary completion
2033
Study completion
2033
First posted
Mar 17, 2021
Registry last updated
May 1, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.